Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Research use of electronic health records: patients' perspectives on contact by researchers.

Brelsford KM, Spratt SE, Beskow LM.

J Am Med Inform Assoc. 2018 Sep 1;25(9):1122-1129. doi: 10.1093/jamia/ocy087.


Medicare utilization, screening, and costs among participants in the Southeastern Diabetes Initiative: A population-based evaluation.

Van Houtven CH, Greiner MA, Heidenfelder B, Spratt SE, Granger BB, Dunham AA, Qualls LG, Curtis LH.

Prim Care Diabetes. 2018 Apr;12(2):172-183. doi: 10.1016/j.pcd.2017.10.003. Epub 2017 Nov 1.


Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitus.

Spratt SE, Pereira K, Granger BB, Batch BC, Phelan M, Pencina M, Miranda ML, Boulware E, Lucas JE, Nelson CL, Neely B, Goldstein BA, Barth P, Richesson RL, Riley IL, Corsino L, McPeek Hinz ER, Rusincovitch S, Green J, Barton AB; DDC Phenotype Group, Kelley C, Hyland K, Tang M, Elliott A, Ruel E, Clark A, Mabrey M, Morrissey KL, Rao J, Hong B, Pierre-Louis M, Kelly K, Jelesoff N.

J Am Med Inform Assoc. 2017 Apr 1;24(e1):e121-e128. doi: 10.1093/jamia/ocw123.


The agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM).

Kelly K, Grau-Sepulveda MV, Goldstein BA, Spratt SE, Wolfley A, Hatfield V, Murphy M, Jones E, Granger BB.

BMJ Open Diabetes Res Care. 2016 Jun 29;4(1):e000182. doi: 10.1136/bmjdrc-2015-000182. eCollection 2016.


Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.

Wu LT, Brady KT, Spratt SE, Dunham AA, Heidenfelder B, Batch BC, Lindblad R, VanVeldhuisen P, Rusincovitch SA, Killeen TK, Ghitza UE.

Contemp Clin Trials. 2016 Jan;46:30-38. doi: 10.1016/j.cct.2015.11.009. Epub 2015 Nov 10.


Barriers to care for patients with diabetes in Durham, North Carolina, why are we withholding life-sustaining medications from the patients who need them the most?

Spratt SE, Feinglos MN, Willis JM.

Expert Rev Endocrinol Metab. 2015 Sep;10(5):459-461. doi: 10.1586/17446651.2015.1069704. Epub 2015 Jul 27.


Methods and initial findings from the Durham Diabetes Coalition: Integrating geospatial health technology and community interventions to reduce death and disability.

Spratt SE, Batch BC, Davis LP, Dunham AA, Easterling M, Feinglos MN, Granger BB, Harris G, Lyn MJ, Maxson PJ, Shah BR, Strauss B, Thomas T, Califf RM, Miranda ML.

J Clin Transl Endocrinol. 2015 Jan 14;2(1):26-36. doi: 10.1016/j.jcte.2014.10.006. eCollection 2015 Mar.


The implementation and evaluation of an evidence-based protocol to treat diabetic ketoacidosis: a quality improvement study.

Evans KJ, Thompson J, Spratt SE, Lien LF, Vorderstrasse A.

Adv Emerg Nurs J. 2014 Apr-Jun;36(2):189-98. doi: 10.1097/TME.0000000000000021.


Missing signposts on the roadmap to quality: a call to improve medication adherence indicators in data collection for population research.

Granger BB, Rusincovitch SA, Avery S, Batch BC, Dunham AA, Feinglos MN, Kelly K, Pierre-Louis M, Spratt SE, Califf RM.

Front Pharmacol. 2013 Nov 7;4:139. doi: 10.3389/fphar.2013.00139. eCollection 2013.


A comparison of phenotype definitions for diabetes mellitus.

Richesson RL, Rusincovitch SA, Wixted D, Batch BC, Feinglos MN, Miranda ML, Hammond WE, Califf RM, Spratt SE.

J Am Med Inform Assoc. 2013 Dec;20(e2):e319-26. doi: 10.1136/amiajnl-2013-001952. Epub 2013 Sep 11.


Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy.

Jiang W, Ladd S, Martsberger C, Feinglos M, Spratt SE, Kuchibhatla M, Green J, Krishnan R.

J Clin Psychopharmacol. 2011 Apr;31(2):207-13. doi: 10.1097/JCP.0b013e31820f4f57.


I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer.

Wong TZ, Jain MK, Spratt SE.

Clin Nucl Med. 2008 Dec;33(12):834-7. doi: 10.1097/RLU.0b013e31818bf135.


Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error reduction with a new nomogram.

Lien LF, Spratt SE, Woods Z, Osborne KK, Feinglos MN.

Endocr Pract. 2005 Jul-Aug;11(4):240-53.


Supplemental Content

Loading ...
Support Center